Contact us
  • +31 615 655 534
  • Laan van Vredenoord, 33 2289 DA Rijswijk, Netherland
  • info@prolifepharma.in
Antibiotic

AGMALIFE SUSPENSION

REGULATORY INFORMATION

MAH & BR: Prolifepharma BV, The Netherlands, EU GMP Certified
Manufacturing site Germany
Language NL/EN
Reference Medicinal Product Augmentin (gsk, UK)
PRODUCT INFORMATION
Active Substance Co-Amoxiclav (Amoxicillin & Clavulanic Acid)
Strength | Dosage Form 457, 312.5, and 156.25 mg Suspension
Indications Agmalife is used in babies & children to treat the following infections:
  • Middle ear and sinus infections
  • Respiratory tract infections
  • Urinary tract infections
  • Skin and soft tissue infections including dental infections
  • Bone and joint infections.
Refer to your doctor or healthcare practitioner before using this medication
Route of Administration Oral
Presentations
  • Agmalife 457 mg: 1 bottle of 100 ml suspension
  • Agmalife 312.5 mg: 1 bottle of 100 ml suspension
  • Agmalife 156.25 mg: 1 bottle of 100 ml suspension
Shelf-life 2 years
Storage conditions
  • Do not store above 25°C. Store in the original package.
  • After reconstitution:
  • Store in a refrigerator at 2 ° C to 8 ° C. Do not freeze.
  • The suspension should be used within 7 days.
ATC Code J01CR02 Amoxicillin & Clavulanic Acid
Pharmacotherapeutic Group ß-Lactum antibacterial penicillin coformulated with a ß-lactamase inhibitor